Gabapentin Capsule
Product Images NDC 71093-121

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71093-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aci Healthcare Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)
This is a formula used to calculate the creatinine clearance rate (CLOr) in patients based on their age, weight, and serum creatinine levels. It is adjusted by multiplying with 0.85 for female patients.*
FDA Label Image

Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

FDA Label Image

Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)
This is a table that depicts the mean pain score during a 4-week fixed dose period. There are three treatment groups: placebo, Gabapentin at 1800 mg per day, and Gabapentin at 2400 mg per day. The pain scores are recorded at baseline and at weeks 1 to 7.*
FDA Label Image

Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
The text presents a figure showing the proportion of responders, defined as patients with more than 50% reduction in pain, in controlled studies for postherpetic neuralgia (PHN) using an unspecified treatment. The proportions are given as percentages and are 32% and 34% for Study 1 and 2, respectively, and both are statistically significant. The text also shows the cost of the treatment (GBP 3600), a placebo (GBP 1800), and another treatment option (GBP 2400), but the relationship between these costs and the PHN studies is unclear.*
FDA Label Image

Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

FDA Label Image

Strides 1

FDA Label Image

Strides 2

Strides 2
This is a description of a medication named "Gabaparin Capsules, USP". Each capsule contains 3005 of Gabaparin, USP. The suggested dosage is one capsule per day. The medication comes in a bottle of 500 capsules. The manufacturer's name is AClHoakbears USA, and the address is 10100V Sarel R, Sute 106, Cord ings L3065. The medication is recommended to be kept out of reach of children. The rest of the text is not helpful for generating a description.*
FDA Label Image

Strides 3

Strides 3
This is a description of medication in capsule form. The dosage amount specified is for a single package. The medication is used for reducing inflammation. The capsules should be stored at a temperature between 59-86F and kept away from children. The name and address of the manufacturer is provided along with the recommended container type for dispensing. Excessive exposure to heat is not recommended. No further information is available due to incomplete or non-readable text.*
FDA Label Image

Vivmed 1

Vivmed 1
This is a description of capsules called NoCT1063120.0 containing 100mg Gabapentin USP. The package includes a medication guide to be given to each patient by the pharmacist. The capsules must be stored at a temperature range of 20°-25°C (68°-77°F). The medication must be kept out of reach of children and dispensed in a child-resistant container. The manufacturer is Vie Sciences Private Limited, located in Tamil Nadu, India, and it is distributed by ACI Healthate USA, Inc. The text also includes manufacturing and distribution codes and information about dosage and storage. The dimensions of the packaging are 120 x 40 mm.*
FDA Label Image

Vivmed 2

Vivmed 2
Gabapentin is a medication available in capsule form with a strength of 400mg and the National Drug Code (NDC) 71093-121-04. The package includes 100 capsules to be stored at room temperature. The medication is manufactured by SIDCO Pharmaceutical Complex and distributed by ACH Healthcare USA, Inc. There is additional information provided separately for each patient.*
FDA Label Image

Vivmed 3

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.